Svetlana Stegalkina YOU? Author Swipe

Last 10y

Boosting neuraminidase immunity in the presence of hemagglutinin with the next generation of influenza vaccines Open

Guadalupe Cortés, Irina V. Ustyugova, Timothy M. Farrell, Clint N McDaniel, Colleen Britain , et al. · 2024

The antigenic landscape of human influenza N2 neuraminidases from 2009 until 2017 Open

João Paulo Portela Catani, Anouk Smet, Tine Ysenbaert, Marnik Vuylsteke, Guy Bottu , et al. · 2024

Human H3N2 influenza viruses are subject to rapid antigenic evolution which translates into frequent updates of the composition of seasonal influenza vaccines. Despite these updates, the effectiveness of influenza vaccines against H3N2-ass…

Author response: The antigenic landscape of human influenza N2 neuraminidases from 2009 until 2017 Open

João Paulo Portela Catani, Anouk Smet, Tine Ysenbaert, Marnik Vuylsteke, Guy Bottu , et al. · 2024

Reviewer #2 (Public Review): The antigenic landscape of human influenza N2 neuraminidases from 2009 until 2017 Open

João Paulo Portela Catani, Anouk Smet, Tine Ysenbaert, Marnik Vuylsteke, Guy Bottu , et al. · 2024

Human H3N2 influenza viruses are subject to rapid antigenic evolution which translates into frequent updates of the composition of seasonal influenza vaccines. Despite these updates, the effectiveness of influenza vaccines against H3N2-ass…

Reviewer #1 (Public Review): The antigenic landscape of human influenza N2 neuraminidases from 2009 until 2017 Open

João Paulo Portela Catani, Anouk Smet, Tine Ysenbaert, Marnik Vuylsteke, Guy Bottu , et al. · 2024

Human H3N2 influenza viruses are subject to rapid antigenic evolution which translates into frequent updates of the composition of seasonal influenza vaccines. Despite these updates, the effectiveness of influenza vaccines against H3N2-ass…

Reviewer #3 (Public Review): The antigenic landscape of human influenza N2 neuraminidases from 2009 until 2017 Open

João Paulo Portela Catani, Anouk Smet, Tine Ysenbaert, Marnik Vuylsteke, Guy Bottu , et al. · 2024

Human H3N2 influenza viruses are subject to rapid antigenic evolution which translates into frequent updates of the composition of seasonal influenza vaccines. Despite these updates, the effectiveness of influenza vaccines against H3N2-ass…

The antigenic landscape of human influenza N2 neuraminidases from 2009 until 2017 Open

João Paulo Portela Catani, Anouk Smet, Tine Ysenbaert, Marnik Vuylsteke, Guy Bottu , et al. · 2024

Human H3N2 influenza viruses are subject to rapid antigenic evolution which translates into frequent updates of the composition of seasonal influenza vaccines. Despite these updates, the effectiveness of influenza vaccines against H3N2-ass…

Author response: The antigenic landscape of human influenza N2 neuraminidases from 2009 until 2017 Open

João Paulo Portela Catani, Anouk Smet, Tine Ysenbaert, Marnik Vuylsteke, Guy Bottu , et al. · 2024

Human H3N2 influenza viruses are subject to rapid antigenic evolution which translates into frequent updates of the composition of seasonal influenza vaccines. Despite these updates, the effectiveness of influenza vaccines against H3N2-ass…

Reviewer #1 (Public Review): The antigenic landscape of human influenza N2 neuraminidases from 2009 until 2017 Open

João Paulo Portela Catani, Anouk Smet, Tine Ysenbaert, Marnik Vuylsteke, Guy Bottu , et al. · 2024

Human H3N2 influenza viruses are subject to rapid antigenic evolution which translates into frequent updates of the composition of seasonal influenza vaccines. Despite these updates, the effectiveness of influenza vaccines against H3N2-ass…

Reviewer #2 (Public Review): The antigenic landscape of human influenza N2 neuraminidases from 2009 until 2017 Open

João Paulo Portela Catani, Anouk Smet, Tine Ysenbaert, Marnik Vuylsteke, Guy Bottu , et al. · 2024

Human H3N2 influenza viruses are subject to rapid antigenic evolution which translates into frequent updates of the composition of seasonal influenza vaccines. Despite these updates, the effectiveness of influenza vaccines against H3N2-ass…

The antigenic landscape of human influenza N2 neuraminidases from 2009 until 2017 Open

João Paulo Portela Catani, Anouk Smet, Tine Ysenbaert, Marnik Vuylsteke, Guy Bottu , et al. · 2024

Human H3N2 influenza viruses are subject to rapid antigenic evolution which translates into frequent updates of the composition of seasonal influenza vaccines. Despite these updates, the effectiveness of influenza vaccines against H3N2-ass…

Reviewer #3 (Public Review): The antigenic landscape of human influenza N2 neuraminidases from 2009 until 2017 Open

João Paulo Portela Catani, Anouk Smet, Tine Ysenbaert, Marnik Vuylsteke, Guy Bottu , et al. · 2024

Human H3N2 influenza viruses are subject to rapid antigenic evolution which translates into frequent updates of the composition of seasonal influenza vaccines. Despite these updates, the effectiveness of influenza vaccines against H3N2-ass…

Author Response: The antigenic landscape of human influenza N2 neuraminidases from 2009 until 2017 Open

João Paulo Portela Catani, Anouk Smet, Tine Ysenbaert, Marnik Vuylsteke, Guy Bottu , et al. · 2024

Human H3N2 influenza viruses are subject to rapid antigenic evolution which translates into frequent updates of the composition of seasonal influenza vaccines. Despite these updates, the effectiveness of influenza vaccines against H3N2-ass…

The antigenic landscape of human influenza N2 neuraminidases from 2009 until 2017 Open

João Paulo Portela Catani, Anouk Smet, Tine Ysenbaert, Marnik Vuylsteke, Guy Bottu , et al. · 2023

Human H3N2 influenza viruses are subject to rapid antigenic evolution which translates into frequent updates of the composition of seasonal influenza vaccines. Despite these updates, the effectiveness of influenza vaccines against H3N2-ass…

Reviewer #1 (Public Review): The antigenic landscape of human influenza N2 neuraminidases from 2009 until 2017 Open

João Paulo Portela Catani, Anouk Smet, Tine Ysenbaert, Marnik Vuylsteke, Guy Bottu , et al. · 2023

Human H3N2 influenza viruses are subject to rapid antigenic evolution which translates into frequent updates of the composition of seasonal influenza vaccines. Despite these updates, the effectiveness of influenza vaccines against H3N2-ass…

The antigenic landscape of human influenza N2 neuraminidases from 2009 until 2017 Open

João Paulo Portela Catani, Anouk Smet, Tine Ysenbaert, Marnik Vuylsteke, Guy Bottu , et al. · 2023

Human H3N2 influenza viruses are subject to rapid antigenic evolution which translates into frequent updates of the composition of seasonal influenza vaccines. Despite these updates, the effectiveness of influenza vaccines against H3N2-ass…

Reviewer #2 (Public Review): The antigenic landscape of human influenza N2 neuraminidases from 2009 until 2017 Open

João Paulo Portela Catani, Anouk Smet, Tine Ysenbaert, Marnik Vuylsteke, Guy Bottu , et al. · 2023

Human H3N2 influenza viruses are subject to rapid antigenic evolution which translates into frequent updates of the composition of seasonal influenza vaccines. Despite these updates, the effectiveness of influenza vaccines against H3N2-ass…

The antigenic landscape of human influenza N2 neuraminidases from 2009 until 2017 Open

João Paulo Portela Catani, Anouk Smet, Tine Ysenbaert, Marnik Vuylsteke, Guy Bottu , et al. · 2023

Human H3N2 influenza viruses are subject to rapid antigenic evolution which translates into frequent updates of the composition of seasonal influenza vaccines. Despite these updates, the effectiveness of influenza vaccines against H3N2-ass…

Pre-existing antibodies directed against a tetramerizing domain enhance the immune response against artificially stabilized soluble tetrameric influenza neuraminidase Open

João Paulo Portela Catani, Emma R. Job, Tine Ysenbaert, Anouk Smet, Satyajit Ray , et al. · 2022

Novel structural insights for a pair of monoclonal antibodies recognizing non-overlapping epitopes of the glucosyltransferase domain of Clostridium difficile toxin B Open

Jinyu Liu, Michael Kothe, Jianxin Zhang, E.O. Oloo, Svetlana Stegalkina , et al. · 2022

Clostridium difficile toxins are the primary causative agents for hospital-acquired diarrhea and pseudomembranous colitis. Numerous monoclonal antibodies (mAbs) targeting different domains of Clostridium difficile toxin have …

Mapping of a Novel H3-Specific Broadly Neutralizing Monoclonal Antibody Targeting the Hemagglutinin Globular Head Isolated from an Elite Influenza Virus-Immunized Donor Exhibiting Serological Breadth Open

Yu Qiu, Svetlana Stegalkina, Jianxin Zhang, Ekaterina Boudanova, Anna Park , et al. · 2019

Influenza viruses escape immunity through continuous antigenic changes that occur predominantly on the viral hemagglutinin (HA). Induction of broadly neutralizing antibodies (bnAbs) targeting conserved epitopes following vaccination is a g…

Incorporation of RG1 epitope concatemers into a self-adjuvanting Flagellin-L2 vaccine broaden durable protection against cutaneous challenge with diverse human papillomavirus genotypes Open

Kirill V. Kalnin, Sudha Chivukula, Timothy Tibbitts, Yanhua Yan, Svetlana Stegalkina , et al. · 2017

Vaccination with flagellin fused L2 multimers provided lasting (>1year) immunity without the need for an exogenous adjuvant. Inclusion of the L2 amino acid 17-38 region in such multi-HPV type fusions expanded the spectrum of protection.

Long-Lasting Cross-Protection Against Influenza A by Neuraminidase and M2e-based immunization strategies Open

Michael Schotsaert, Tine Ysenbaert, Anouk Smet, Bert Schepens, Dieter Vanderschaeghe , et al. · 2016

Correction for Lam et al., Antibodies to PhnD Inhibit Staphylococcal Biofilms Open

Hubert Lam, Augustus Kesselly, Svetlana Stegalkina, Robert L. Charlebois, Raymond P. Oomen , et al. · 2015

Volume 82, no. 9, p. [3764–3774][1], 2014. Page 3764: The byline and affiliation lines should read as given above. Page 3773, column 1, Acknowledgments. Lines 39–41 should read as follows. “We thank P. D. Fey for strains and plasmids, J. …

Fetching topic information...